Summary
Ventricular fibrillation ("VF" or "V-fib") is a life-threatening cardiac arrhythmia characterized by disorganized, high-frequency ventricular contractions that result in diminished cardiac output and hemodynamic collapse. V-fib usually begins with ventricular tachycardia and appears as a very irregular rhythm with indiscernible P waves or QRS complexes on ECG. The most common underlying condition is coronary artery disease, but V-fib may also be caused by other cardiovascular diseases or external factors (e.g., drugs, electricity). V-fib is frequently preceded by ventricular flutter (“V-flut”), which features very rapid sinusoidal QRS complexes that can not be distinguished from T waves. Some patients with V-fib may present with early signs, including chest pain, palpitations, and dizziness. However, V-fib usually causes sudden hemodynamic instability that results in loss of consciousness and, ultimately, sudden cardiac death. Therefore, immediate defibrillation and resuscitation are vital for survival.
Etiology
- Underlying cardiovascular disease
- Most common: coronary artery disease (CAD)
- Others: previous myocardial infarction, myocarditis, cardiomyopathy; , severe congestive heart failure, heart valve disease
- Congenital heart defects (e.g., pulmonary atresia)
- Electrolyte imbalances (e.g., hypokalemia, hyperkalemia) [1]
- Electrophysiologic disorders
Pathophysiology
- Normal electrical conduction can be disrupted by re-entry; → chaotic, circulating excitation of the myocardium (= ventricular fibrillation); → simultaneous contractions at multiple foci → insufficient cardiac output → hemodynamic collapse → loss of consciousness and possibly death (sudden cardiac death)
-
Re-entry can be caused by
- Changes to the conduction pathway; (e.g., unexcitable scar tissue as a result of past myocardial infarction)
- Abnormal pattern of excitation, for example:
- If the period of activation and recovery of myocardial cells becomes greater than the duration of an action potential (as in long-QT syndrome)
- If excitation occurs outside of the normal pattern of activation (premature ventricular complex, PVC )
Clinical features
- Possible early signs
- Ultimately: loss of consciousness, death
Diagnostics
ECG findings
-
Ventricular fibrillation
- Commonly preceded by ventricular tachycardia
- General appearance
- Arrhythmic, fibrillatory baseline; , usually > 300 bpm
- Erratic undulations with indiscernible QRS complexes
- No atrial P waves
-
Ventricular flutter: ventricular rates of ∼ 240–300 bpm
- Frequently transitions to V-fib
Evaluation of underlying conditions
- Conducted during or directly after initial management of patients
- ECG: specific findings may indicate underlying condition (see above)
-
Laboratory
- Cardiac enzymes
- Electrolytes
- TSH
- Drug levels and toxicology screen
- Arterial blood gases
-
Imaging
- Coronary angiography
- Echocardiography
- Nuclear imaging
Treatment
-
Resuscitation for V-fib
- Advanced Cardiac Life Support (ACLS)
- If V-fib does not respond to the standard ACLS protocol (refractory V-fib), consider administration of lidocaine, procainamide, or magnesium
-
Post-resuscitation care
-
Intensive care monitoring
- Control/management of vital signs and removal of acute metabolic imbalances (e.g., electrolyte disturbances)
- Mild therapeutic hypothermia
- Maintain application of antiarrhythmics that were used during successful resuscitation (usually IV amiodarone or IV lidocaine)
- Consider administration of beta blockers
- Treat underlying causes (e.g., treatment of CAD)
- ICD; (implantable cardioverter-defibrillator) in patients without a readily reversible or treatable cause and/or with a high risk of recurrent, hemodynamically significant V-fib
-
Intensive care monitoring
Related One-Minute Telegram
- One-Minute Telegram 65-2022-2/3: Better outcomes with alternative defibrillation strategies
Interested in the newest medical research, distilled down to just one minute? Sign up for the One-Minute Telegram in “Tips and links” below.